DE60230764D1 - Neues oberflächenexponiertes, immunglobulin d bindendes protein aus moraxella catarrhalis - Google Patents
Neues oberflächenexponiertes, immunglobulin d bindendes protein aus moraxella catarrhalisInfo
- Publication number
- DE60230764D1 DE60230764D1 DE60230764T DE60230764T DE60230764D1 DE 60230764 D1 DE60230764 D1 DE 60230764D1 DE 60230764 T DE60230764 T DE 60230764T DE 60230764 T DE60230764 T DE 60230764T DE 60230764 D1 DE60230764 D1 DE 60230764D1
- Authority
- DE
- Germany
- Prior art keywords
- surface exposed
- igd
- moraxella catarrhalis
- exposed protein
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 241000588655 Moraxella catarrhalis Species 0.000 title abstract 3
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 239000012634 fragment Substances 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102410A SE0102410D0 (sv) | 2001-07-04 | 2001-07-04 | Novel surface exposed immunoglobulin D-binding protein from moraxella catarrhalis |
| PCT/SE2002/001299 WO2003004651A1 (en) | 2001-07-04 | 2002-07-01 | Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60230764D1 true DE60230764D1 (de) | 2009-02-26 |
Family
ID=20284749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60230764T Expired - Lifetime DE60230764D1 (de) | 2001-07-04 | 2002-07-01 | Neues oberflächenexponiertes, immunglobulin d bindendes protein aus moraxella catarrhalis |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7470432B2 (de) |
| EP (1) | EP1409684B1 (de) |
| JP (1) | JP4443922B2 (de) |
| AT (1) | ATE420181T1 (de) |
| AU (1) | AU2002314688C1 (de) |
| CA (1) | CA2452695A1 (de) |
| DE (1) | DE60230764D1 (de) |
| ES (1) | ES2316576T3 (de) |
| NZ (1) | NZ530291A (de) |
| SE (1) | SE0102410D0 (de) |
| WO (1) | WO2003004651A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080042865A (ko) | 2005-08-10 | 2008-05-15 | 아르네 포르스그렌 아베 | 모락셀라 카타랄리스와 상피세포, 세포외기질 단백질 및보체계의 상호작용 |
| US9156916B2 (en) | 2006-04-27 | 2015-10-13 | The University Of Sydney | Modulation of T helper cell-mediated immune responses |
| US20140286977A1 (en) * | 2011-05-11 | 2014-09-25 | Riesbeck Healthcare Sweden Ab | Protein F - A Novel Haemophilus Influenzae Adhesin with Laminin and Vitronectin binding Properties |
| EP3668460A4 (de) | 2017-08-17 | 2021-05-05 | Aspip Inc. | Verfahren, vorrichtung und system zur behandlung von erhöhtem augeninnendruck |
| CN111157735B (zh) * | 2018-11-07 | 2023-02-07 | 广州万孚生物技术股份有限公司 | 凝集性卡他莫拉菌单克隆抗体及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440425B1 (en) | 1995-05-01 | 2002-08-27 | Aventis Pasteur Limited | High molecular weight major outer membrane protein of moraxella |
| US6335018B1 (en) * | 1995-05-01 | 2002-01-01 | Aventis Pasteur Limited | High molecular weight major outer membrane protein of moraxella |
| US7341727B1 (en) * | 1996-05-03 | 2008-03-11 | Emergent Product Development Gaithersburg Inc. | M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same |
| US6673910B1 (en) * | 1999-04-08 | 2004-01-06 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics |
| US6391313B1 (en) * | 1999-07-15 | 2002-05-21 | Aventis Pasteur Limited | Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalis |
| EP1203082A1 (de) * | 1999-07-27 | 2002-05-08 | Aventis Pasteur Limited | Rekombinantes hochmolekulares "major outer membrane" protein aus moraxella |
-
2001
- 2001-07-04 SE SE0102410A patent/SE0102410D0/xx unknown
-
2002
- 2002-07-01 AU AU2002314688A patent/AU2002314688C1/en not_active Ceased
- 2002-07-01 CA CA002452695A patent/CA2452695A1/en not_active Abandoned
- 2002-07-01 AT AT02741607T patent/ATE420181T1/de not_active IP Right Cessation
- 2002-07-01 WO PCT/SE2002/001299 patent/WO2003004651A1/en active IP Right Grant
- 2002-07-01 EP EP02741607A patent/EP1409684B1/de not_active Expired - Lifetime
- 2002-07-01 US US10/480,456 patent/US7470432B2/en not_active Expired - Fee Related
- 2002-07-01 ES ES02741607T patent/ES2316576T3/es not_active Expired - Lifetime
- 2002-07-01 DE DE60230764T patent/DE60230764D1/de not_active Expired - Lifetime
- 2002-07-01 JP JP2003510809A patent/JP4443922B2/ja not_active Expired - Fee Related
- 2002-07-01 NZ NZ530291A patent/NZ530291A/en not_active IP Right Cessation
-
2008
- 2008-05-21 US US12/124,404 patent/US7981434B2/en not_active Expired - Fee Related
-
2011
- 2011-06-08 US US13/155,502 patent/US20110280910A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP4443922B2 (ja) | 2010-03-31 |
| EP1409684A1 (de) | 2004-04-21 |
| AU2002314688B2 (en) | 2007-09-20 |
| EP1409684B1 (de) | 2009-01-07 |
| ATE420181T1 (de) | 2009-01-15 |
| US20100098729A1 (en) | 2010-04-22 |
| JP2005500837A (ja) | 2005-01-13 |
| CA2452695A1 (en) | 2003-01-16 |
| WO2003004651A1 (en) | 2003-01-16 |
| US20050027104A1 (en) | 2005-02-03 |
| SE0102410D0 (sv) | 2001-07-04 |
| US20110280910A1 (en) | 2011-11-17 |
| ES2316576T3 (es) | 2009-04-16 |
| US7981434B2 (en) | 2011-07-19 |
| US7470432B2 (en) | 2008-12-30 |
| NZ530291A (en) | 2005-07-29 |
| AU2002314688C1 (en) | 2008-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9702714A (es) | Produccion de peptidos en plantas como fusiones de proteinas con revestimiento viral. | |
| JP2019521643A5 (de) | ||
| BG102983A (en) | Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application | |
| WO2001031019A3 (en) | Neisserial antigenic peptides | |
| WO2008089053A3 (en) | Gp100-specific t cell receptors and related materials and methods of use | |
| ATE292685T1 (de) | Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe | |
| CA2572555A1 (en) | Fusion protein of porcine reproductive and respiratory syndrome virus as prrs vaccine | |
| WO2005071088A3 (en) | Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof | |
| WO2005120565A8 (en) | Sars vaccines and methods to produce highly potent antibodies | |
| JP2009520758A5 (de) | ||
| WO2006107924B1 (en) | Ehrlichia canis diva (differentiate infected from vaccinated animals) | |
| WO2002072036A3 (en) | Compositions and methods comprising west nile virus polypeptides | |
| WO1998055606A3 (en) | Lactoferrin receptor genes of moraxella | |
| JP2019526274A5 (de) | ||
| WO2001066778A3 (en) | Production of foreign polypeptides in plants as viral coat protein fusions | |
| WO2006131749A3 (en) | Scaffold | |
| Phan et al. | Neutralizing immune responses induced by oligomeric H5N1-hemagglutinins from plants | |
| WO2010007144A3 (en) | Mutated netrin-4 proteins, fragments thereof and their uses as drugs | |
| DE60230764D1 (de) | Neues oberflächenexponiertes, immunglobulin d bindendes protein aus moraxella catarrhalis | |
| RU2019118427A (ru) | Нацеленный на эритроциты фактор viii и способ его применения | |
| WO2000012535A3 (en) | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
| DE60230312D1 (de) | Verfahren zur proteinreinigung | |
| ATE315787T1 (de) | Methoden zur identifizierung von modulatoren wechselwirkender proteine | |
| CN101516915A (zh) | 抗肥胖致免疫杂交多肽及含有所述多肽的抗肥胖疫苗组合物 | |
| WO2006007366A3 (en) | SKIN IMMUNIZATION USING LT-STa FUSION PROTEINS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |